The United States Food and Drug Administration (FDA) has approved Golden Rice, marking the third positive international assessment for the genetically engineered biofortified crop. Previously,
Investigators at Imperial College London synthesized the compound IMP-1088, a picomolar dual inhibitor of the human enzymes N-myristoyltransferases NMT1 and NMT2. N-myristoyltransferase catalyzes the transfer